Skip to content

Anesthetic spread of ultrasound guided intertransverse process block in different volumes of ropivacaine: a computed tomography image study

Anesthetic spread of ultrasound guided intertransverse process block in different volumes of ropivacaine: a computed tomography image study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082665
Enrollment
Unknown
Registered
2024-04-03
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional anesthesia and pulmonary nodule

Interventions

Group A:Intertransverse process block with 0.3 ml/kg of ropivacaine 0.375% ( contain 0.03 ml/kg (9 mg/kg) iodohydrin)
Group B:Intertransverse process block with 0.4 ml/kg of ropivacaine 0.375% ( contain 0.04 ml/kg (12 mg/kg) iodohydrin)
Group C:Intertransverse process block with 0.5 ml/kg of ropivacaine 0.375% ( contain 0.05 ml/kg (15 mg/kg) iodohydrin)

Sponsors

The First Affiliated Hospital of Gannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) American Society of Anesthesiologist physical status Classification I-II; (2) Patients aged 18-75 who plan to undergo computer tomography guided percutaneous localization or microwave ablation of pulmonary nodules; (3) Agree to participate in the study; (4) Can understand the relevant evaluation content; (5) BMI 18.5-28 kg/m2.

Exclusion criteria

Exclusion criteria: (1) Refusal to participate in research; (2) With severe comorbidities, including but not limited to renal dysfunction (creatinine>442) µmol/L or renal replacement therapy, liver dysfunction (Child Pugh C grade), and other serious cardiovascular and pulmonary diseases; (3) Contraindication of nerve block, including but not limited to be coagulation disorder, infection at the injection site, allergic to local anesthetic drug; (4) Allergic to contrast agents or other medications required for surgical procedures; (5) Individuals with anatomical abnormalities who are unable to undergo nerve block.

Design outcomes

Primary

MeasureTime frame
The distribution patterns of local anesthetics in nine predefined anatomical areas ( retro-superior costotransverse ligament space (RS); intervertebral foramen (IF); costotransverse space (CTS); erector spinae fascia (ESF); intercostal space (ICS); epidural space (ES); sympathetic ganglion (SG); lateral recess (LR); mediastinal compartments (MC) );

Secondary

MeasureTime frame
Dermatomal distribution of sensory loss (after surgery);

Countries

China

Contacts

Public ContactLifang Zhan

The First Affiliated Hospital of Gannan Medical College

zhanlifangzouping@163.com+86 1587971530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026